MELBOURNE, Australia and INDIANAPOLIS, Oct. 14, 2025 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today provides an update on its commercial and operational performance for the quarter ended 30 September 2025 (Q3 2025). All figures are in USD unless stated otherwise. Q3 2025 HighlightsQ3 2025 unaudited group revenue of approximately $206 million, up 53% year-over-year. FY 2025 revenue guidance increased to $800 million to $820 million1. Gozellix® now fully reimbursed by Centers for Medicare and Medicaid Services (CMS): Level II HCPCS2 code and Transitional Pass-Through (TPT) payment status effective 1 October 20253. Illuccix® now approved in 19 European markets4 and the United Kingdom (UK); commercial launch has commenced in the UK, Germany, France, Finland, Sweden, Norway and Denmark.  First...

PERTH, Australia, Oct. 13, 2025 (GLOBE NEWSWIRE) — Paladin Energy Ltd (ASX:PDN, TSX:PDN, OTCQX:PALAF) (“Paladin” or the “Company”) advises that it has released its quarterly activities report for the three month period ended 30 September 2025 (“September 2025 Quarter Results”). The Company has also released an accompanying presentation on the September 2025 Quarter Results. The quarterly activities report and presentation are available on Paladin’s website (https://www.paladinenergy.com.au/investors/asx-announcements/). For further information contact:Investor RelationsHead Office Paula RaffoPaladin Investor Relations T: +61 8 9423 8100E: paula.raffo@paladinenergy.com.auCanadaBob HemmerlingPaladin Investor Relations T: +1 250-868-8140E: Bob.Hemmerling@paladinenergy.caMediaHead OfficeAnthony HasluckPaladin Corporate AffairsT:...

Management to Host Conference Call Tomorrow at 9:00 a.m. Eastern Time DURANGO, Colo., Oct. 13, 2025 (GLOBE NEWSWIRE) — Rocky Mountain Chocolate Factory, Inc. (Nasdaq: RMCF) (the “Company”, “we”, “RMCF”, or “Rocky Mountain Chocolate”), America’s Chocolatier™ and a leading franchiser of a premium chocolate and confectionary retail store concept, is reporting financial and operating results for its second quarter of fiscal 2026, which ended August 31, 2025. “We’ve taken meaningful steps to transform and modernize our business and are beginning to see early signs of progress,” said Jeff Geygan, Interim CEO of the Company. “During the quarter, we focused on strengthening our operations and laying the groundwork for scalable growth. Our ERP and POS systems are providing us with clearer insight into store performance and customer...

                                                          Clermont-Ferrand – October 13, 2025 – 5:50pm COMPAGNIE GÉNÉRALE DES ÉTABLISSEMENTS MICHELIN Michelin adjusts outlook for 2025 financial year Based on fresh Q3 financial results which reflect further deterioration of the business environment versus expectations made in July, Michelin group has decided to adjust the outlook for 2025, ahead of the Q3 sales release planned on October 22. Besides North America, Michelin has posted year-on-year volume growth in the third quarter, which demonstrates the ability to drive growth and value across the various market segments, in a chaotic business context and despite near-term uncertainties weighing on demand of B2C and B2B customers. However, the North American business deteriorated more sharply than expected: Q3 sales volume decreased...

Preliminary Third Quarter Net Sales and Adjusted EBITDA Exceeded our Guidance Preliminary Third Quarter Net Sales Represent 26% Year over Year Growth RENO, Nev., Oct. 13, 2025 (GLOBE NEWSWIRE) — Dragonfly Energy Holdings Corp. (“Dragonfly Energy” or the “Company”) (Nasdaq: DFLI), an industry leader in energy storage and battery technology, today announced preliminary third quarter 2025 Net Sales and Adjusted EBITDA. The Company anticipates third quarter 2025 Net Sales of $16.0 million and Adjusted EBITDA of $(2.2) million, above guidance of $15.9 million for Net Sales and above guidance of $(2.7) million for Adjusted EBITDA. Anticipated results represent 26% year-over-year growth in Net Sales and an approximately $3.3 million reduction in Adjusted EBITDA loss. “Preliminary third quarter Net Sales and Adjusted EBITDA exceeded our...

Sales Highlights (unaudited):Global • Q1 sales AUD$2.0 million up 34% on prior comparative period (pcp)     Australia • Q1 sales AUD$1.6 million up 52% on pcp     Canada • Q1 sales AUD$0.0 million down 92% on pcp     USA • Q1 sales AUD$0.4 million up 44% on pcpMELBOURNE, Australia, Oct. 13, 2025 (GLOBE NEWSWIRE) — Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company is pleased to announce continued sales growth (unaudited) of Travelan®, an over-the-counter immune supplement that targets pathogenic bacteria and the toxins they produce in the gastrointestinal (GI) tract.Continued growth (+34% on pcp) in Australia can be contributed to: (1) increased awareness and consideration driven by extensive digital and social media marketing. (2) same store...

Ad hoc announcement pursuant to Article 53 of the SIX Exchange Regulation Listing Rules Q3 2025 Qualitative Update: Tecan reports mid-single-digit local currency growth in the third quarter and confirms full-year 2025 outlook Männedorf, Switzerland, October 13, 2025 – The Tecan Group (SIX Swiss Exchange: TECN) today provided a qualitative update on its performance for the third quarter of 2025.Sales for the third quarter increased by a mid-single-digit percentage in local currencies, representing a further sequential improvement after a mid-single-digit decline in Q1 and a low-single-digit decline in Q2. At the segment level, the Life Sciences Business recorded a low-single-digit sales decline and the Partnering Business achieved a sales increase in the low teens percentage range, both in local currencies and in line with expectations....

PRESS RELEASE Bloomberg (THEON:NA) / Reuters (THEON.AS)11 October 2025 – Theon International Plc (THEON) has entered into a definitive agreement with HLD Europe SCA, Invest Prince Henri SCA and Invest Gamma Sarl, investment companies belonging to Groupe HLD (HLD), to purchase a 9.8% stake in Exosens SA (EXOSENS) for a cash consideration of €268.7 million corresponding to €54.0 per share. EXOSENS is a leading French company specializing in advanced electro-optical technologies, including light amplification, detection and imaging systems. Following the completion of the transaction, THEON will become the second largest shareholder in EXOSENS, after Groupe HLD. The closing of the transaction remains subject to regulatory notifications in a selectednumber of countries, and is expected to take place in early Q1 2026. In connection with the...

WEST PALM BEACH, Fla., Oct. 10, 2025 (GLOBE NEWSWIRE) — Solitron Devices, Inc. (OTC Pink: SODI) (“Solitron” or the “Company”) is pleased to announce fiscal 2026 second quarter results.  FISCAL 2026 SECOND QUARTER HIGHLIGHTS –Net sales increased 11% to approximately $3.99 million in the fiscal 2026 second quarter versus $3.58 million in the fiscal 2025 second quarter. Net bookings increased 147% to $4.32 million in the fiscal 2026 second quarter versus $1.75 million in the prior year second quarter. Backlog increased 146% to $18.64 million at the end of the fiscal 2026 second quarter as compared to $7.57 million at the end of the fiscal 2025 second quarter. Net income (loss) was ($0.23) million, or ($0.11) per share, for the fiscal 2026 second quarter versus net income of $0.02 million, or $.01 per share, for the fiscal 2025 second...

HINGHAM, Mass., Oct. 10, 2025 (GLOBE NEWSWIRE) — HINGHAM INSTITUTION FOR SAVINGS (NASDAQ: HIFS), Hingham, Massachusetts announced results for the quarter ended September 30, 2025. Earnings Net income for the quarter ended September 30, 2025 was $17,295,000 or $7.93 per share basic and $7.85 per share diluted, as compared to $5,846,000 or $2.68 per share basic and $2.66 per share diluted for the same period last year. The Bank’s annualized return on average equity for the third quarter of 2025 was 15.15%, and the annualized return on average assets was 1.54%, as compared to 5.52% and 0.54% for the same period last year. Net income per share (diluted) for the third quarter of 2025 increased by 195.1% compared to the same period in 2024. Core net income for the quarter ended September 30, 2025, which represents net income excluding...